![](/img/cover-not-exists.png)
The gamma-secretase inhibitor BMS-708163 causes dose-dependent reductions in CSF Aβ40 levels in patients with mild-to-moderate Alzheimer's disease (AD)
Charles Albright, Niels Andreasen, Lennart Minthon, Kaj Blennow, Howard Feldman, Holly Soares, Flora Berisha, Paul Rhyne, Linda Rollin, Vlad Coric, Robert BermanVolume:
7
Year:
2011
Language:
english
DOI:
10.1016/j.jalz.2011.05.905
File:
PDF, 58 KB
english, 2011